Previous studies have reported detection of high p-eIF2α expression levels in tumor samples compared with in matched noncancerous tissues, in cancers including bronchioloalveolar carcinomas of the lung16, Hodgkin lymphoma17, gastrointestinal carcinomas18 and malignant melanoma19. The gene discussed is EIF2A; the disease is cancer.